Terms: = Leukemia AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Diagnosis
12 results:
1. MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients.
Catalano G; Zaza A; Banella C; Pelosi E; Castelli G; de Marinis E; Smigliani A; Travaglini S; Ottone T; Divona M; Del Principe MI; Buccisano F; Maurillo L; Ammatuna E; Testa U; Nervi C; Venditti A; Voso MT; Noguera NI
Leukemia; 2023 Aug; 37(8):1600-1610. PubMed ID: 37349598
[TBL] [Abstract] [Full Text] [Related]
2. Serum levels of FAK and some of its effectors in adult AML: correlation with prognostic factors and survival.
El-Sisi MG; Radwan SM; Saeed AM; El-Mesallamy HO
Mol Cell Biochem; 2021 May; 476(5):1949-1963. PubMed ID: 33507464
[TBL] [Abstract] [Full Text] [Related]
3. First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET.
Krebs S; Veach DR; Carter LM; Grkovski M; Fornier M; Mauro MJ; Voss MH; Danila DC; Burnazi E; Null M; Staton K; Pressl C; Beattie BJ; Zanzonico P; Weber WA; Lyashchenko SK; Lewis JS; Larson SM; Dunphy MPS
J Nucl Med; 2020 Nov; 61(11):1580-1587. PubMed ID: 32169913
[TBL] [Abstract] [Full Text] [Related]
4. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia.
Guo Y
Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110
[TBL] [Abstract] [Full Text] [Related]
5. JAM-C Identifies src Family Kinase-Activated leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid leukemia.
De Grandis M; Bardin F; Fauriat C; Zemmour C; El-Kaoutari A; Sergé A; Granjeaud S; Pouyet L; Montersino C; Chretien AS; Mozziconacci MJ; Castellano R; Bidaut G; Boher JM; Collette Y; Mancini SJC; Vey N; Aurrand-Lions M
Cancer Res; 2017 Dec; 77(23):6627-6640. PubMed ID: 28972073
[TBL] [Abstract] [Full Text] [Related]
6. Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib.
Brümmendorf TH; Cortes JE; Khoury HJ; Kantarjian HM; Kim DW; Schafhausen P; Conlan MG; Shapiro M; Turnbull K; Leip E; Gambacorti-Passerini C; Lipton JH
Br J Haematol; 2016 Jan; 172(1):97-110. PubMed ID: 26537529
[TBL] [Abstract] [Full Text] [Related]
7. Current strategies in the diagnosis and management of chronic neutrophilic leukemia.
Otgonbat A; Zhao M
Chin Med J (Engl); 2014; 127(24):4258-62. PubMed ID: 25533830
[TBL] [Abstract] [Full Text] [Related]
8. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
Gotlib J; Maxson JE; George TI; Tyner JW
Blood; 2013 Sep; 122(10):1707-11. PubMed ID: 23896413
[TBL] [Abstract] [Full Text] [Related]
9. [Screen of phosphopeptide specific for acute leukemia].
Peng HL; Dai CW; Zhang GS; Gu TL; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):163-8. PubMed ID: 22781597
[TBL] [Abstract] [Full Text] [Related]
10. Identification of e6a2 BCR-ABL fusion in a Philadelphia-positive CML with marked basophilia: implications for treatment strategy.
Rohon P; Divoka M; Calabkova L; Mojzikova R; Katrincsakova B; Rusinakova Z; Lapcikova A; Raida L; Faber E; Jarosova M; Divoky V; Indrak K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Jun; 155(2):187-90. PubMed ID: 21804629
[TBL] [Abstract] [Full Text] [Related]
11. Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy.
Rohon P; Porkka K; Mustjoki S
Eur J Haematol; 2010 Nov; 85(5):387-98. PubMed ID: 20662899
[TBL] [Abstract] [Full Text] [Related]
12. Contribution of immunological markers to the diagnosis and prognosis of human leukemia.
von Fliedner V
Eur J Cancer Clin Oncol; 1985 Mar; 21(3):347-53. PubMed ID: 3159579
[TBL] [Abstract] [Full Text] [Related]
